☆ 4.5 Article

UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma

PATHOLOGY RESEARCH AND PRACTICE (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule

Aimee R. Kreimer et al.

Summary: Many countries burdened by cervical cancer have not provided HPV vaccines to most eligible girls, resulting in limited access to screening and treatment. However, the increased vaccine supply and single-dose recommendation provide an opportunity to expand vaccination and prevent millions of projected cervical cancer cases.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

Review Oncology

Ubiquitin C-terminal hydrolase-L1: A new cancer marker and therapeutic target with dual effects (Review)

Xiaowei Wang et al.

Summary: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is a lesser-known member of the deubiquitinating enzyme family that has both deubiquitinase and ubiquitin ligase activity and plays a role in stabilizing ubiquitin. It was first discovered in the brain and is involved in regulating cell differentiation, proliferation, transcriptional regulation, and many other biological processes. UCH-L1 is predominantly expressed in the brain and has a role in tumor promotion or inhibition. The effect of UCH-L1 dysregulation in cancer and its underlying mechanisms are still debated. Extensive research into the role of UCH-L1 in different types of cancer is vital for future UCH-L1-associated cancer treatment. This review provides insights into the molecular structure and function of UCH-L1, summarizes its role in different types of cancer, and discusses how novel treatment targets contribute to cancer research.

ONCOLOGY LETTERS (2023)

Add to Collection

Review Oncology

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

Milon Mondal et al.

Summary: Breast cancer, particularly metastatic ER- breast cancer and TNBC subtypes, has limited treatment options and low survival rates. UCHL1, highly expressed in these cancers, has emerged as a potential drug target in breast cancer with the recent discovery of small-molecule inhibitors.

BRITISH JOURNAL OF CANCER (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review

Riccardo Di Fiore et al.

Summary: Cervical cancer is the fourth most common gynecological malignancy worldwide, mostly associated with high-risk human papillomavirus infection. While cervical Pap smear screening and vaccines have effectively reduced the incidence and death rate of cervical cancer, their accessibility varies across different societies. Prognosis for advanced or recurrent cervical cancer is poor, with a maximum one-year relative survival rate of 20%. Cancer stem cells may play a crucial role in the tumorigenesis, metastasis, relapse, and resistance to treatment of cervical cancer, highlighting their potential as therapeutic targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for specific inhibition of the deubiquitinase UCHL1

Christian Grethe et al.

Summary: This study reveals the structural basis for the specific inhibition of UCHL1 and introduces chemogenomic probes that can be used for investigating UCHL1 functions in living cells. Understanding the molecular roles of UCHL1 is important for studying cancer invasiveness and neurodegeneration. The newly developed probes provide valuable tools for cellular investigations of UCHL1.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Oncology

HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage

Gaia Giannone et al.

Summary: HPV vaccination plays a crucial role in eliminating cervical cancer and other HPV-related malignancies. The global strategy aims to vaccinate 90% of young girls worldwide by 2030, requiring optimization of vaccination programs, increased financial support, and awareness.

CANCER TREATMENT REVIEWS (2022)

Add to Collection

Article Cell Biology

UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells

Jae Eun Lee et al.

Summary: The study revealed that UCH-L1 and UCH-L3 in prostate cancer cells regulate stem cell-like properties differently, with UCH-L1 promoting CSC-like characteristics and UCH-L3 repressing them. These effects were mediated through the PI3 K/Akt signaling pathway, offering new therapeutic strategies for overcoming CSCs in prostate cancers.

ANIMAL CELLS AND SYSTEMS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells

Qin Wang et al.

Summary: The study demonstrates that using gelatinase-stimuli nanoparticles loaded with Sal-Docetaxel can simultaneously inhibit tumor stem cells and non-stem cells, enhance anti-tumor efficacy, and reduce side effects.

DRUG DELIVERY (2021)

Add to Collection

Article Cell Biology

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)

Yin Zhao et al.

CELLS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity

Nattawadee Panyain et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Add to Collection

Review Oncology

Cervical cancer in low and middle-income countries

Rodney Hull et al.

ONCOLOGY LETTERS (2020)

Add to Collection

Article Medicine, Research & Experimental

UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer

Xi-Sha Chen et al.

THERANOSTICS (2020)

Add to Collection

Article Medicine, Research & Experimental

The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase

Xinyuan Ding et al.

THERANOSTICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Role of UCHL1 in axonal injury and functional recovery after cerebral ischemia

Hao Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Article Oncology

UCHL1 loss alters the cell cycle in metastatic pancreatic neuroendocrine tumors

Brendan M. Finnerty et al.

ENDOCRINE-RELATED CANCER (2019)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Review Medicine, General & Internal

Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Joy Melnikow et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Editorial Material Obstetrics & Gynecology

FIGO Cancer Report 2018

Neerja Bhatla et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)

Add to Collection

Review Oncology

Stem cell fate in cancer growth, progression and therapy resistance

Nikki K. Lytle et al.

NATURE REVIEWS CANCER (2018)

Add to Collection

Review Oncology

Cancer stem cells (CSCs), cervical CSCs and targeted therapies

Ruixia Huang et al.

ONCOTARGET (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Cancer stem cells revisited

Eduard Batlle et al.

NATURE MEDICINE (2017)

Add to Collection

Review Oncology

Overview of Cancer Stem Cells and Stemness for Community Oncologists

Justin D. Lathia et al.

TARGETED ONCOLOGY (2017)

Add to Collection

Review Oncology

EMT in cervical cancer: Its role in tumour progression and response to therapy

Rehana Qureshi et al.

CANCER LETTERS (2015)

Add to Collection

Article Oncology

Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma

Shuier Zheng et al.

CANCER LETTERS (2015)

Add to Collection

Review Cell & Tissue Engineering

Evolution of the Cancer Stem Cell Model

Antonija Kreso et al.

CELL STEM CELL (2014)

Add to Collection

Article Obstetrics & Gynecology

Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells

Shoko Kumazawa et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2014)

Add to Collection

Article Oncology

Rescue of silenced UCHL1 and IGFBP4 expression suppresses clonogenicity of giant cell tumor-derived stromal cells

Joerg Fellenberg et al.

CANCER LETTERS (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Could Dysregulation of UPS be a Common Underlying Mechanism for Cancer and Neurodegeneration? Lessons from UCHL1

Javier H. Jara et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis

H. J. Kim et al.

ONCOGENE (2009)

Add to Collection

Article Gastroenterology & Hepatology

Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors

Jun Yu et al.

HEPATOLOGY (2008)

Add to Collection

Article Urology & Nephrology

CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma

Ichiro Kagara et al.

JOURNAL OF UROLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.